Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Cancer Treatment and Research Communications
|
December 21, 2020
Exposure to a mycovirus containing Aspergillus Flavus reproduces acute lymphoblastic leukemia cell surface and genetic markers in cells from patients in remission and not controls
Cameron K Tebbi, Aruna Badiga, Eva Sahakian, et al.
Current Pharmaceutical Design
|
January 30, 2010
Circumventing immune tolerance through epigenetic modification
Jason A Dubovsky, Alejandro Villagra, John J Powers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2009
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen
Jason A Dubovsky, Douglas G McNeel, John J Powers, et al.
Leukemia Research
|
March 8, 2011
Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidine
Jason A Dubovsky, John J Powers, Yang Gao, et al.
Frontiers in Immunology
|
December 17, 2020
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
Kamira Maharaj, John J Powers, Melanie Mediavilla-Varela, et al.
Leukemia Research
|
September 25, 2010
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
Jason A Dubovsky, Daniel Wang, John J Powers, et al.
Leukemia & Lymphoma
|
January 29, 2011
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
John J Powers, Jason A Dubovsky, P K Epling-Burnette, et al.
Frontiers in Oncology
|
December 19, 2022
Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma
Ahmad A Tarhini, Wissam B Hanayneh, John J Powers, et al.
Journal of Pediatric Hematology/Oncology
|
June 25, 2020
Plasma of Acute Lymphoblastic Leukemia Patients React to the Culture of a Mycovirus Containing Aspergillus flavus
Cameron K Tebbi, Aruna Badiga, Eva Sahakian, et al.
Biorxiv : the Preprint Server for Biology
|
April 24, 2026
Adaptive Responses Directed by CREB Control Epithelial-Mesenchymal Plasticity in Cancer
Kshitij Parag-Sharma, Harish Bharambe, John J Powers, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Cancer Treatment and Research Communications
|
December 21, 2020
Exposure to a mycovirus containing Aspergillus Flavus reproduces acute lymphoblastic leukemia cell surface and genetic markers in cells from patients in remission and not controls
Cameron K Tebbi, Aruna Badiga, Eva Sahakian, et al.
Current Pharmaceutical Design
|
January 30, 2010
Circumventing immune tolerance through epigenetic modification
Jason A Dubovsky, Alejandro Villagra, John J Powers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2009
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen
Jason A Dubovsky, Douglas G McNeel, John J Powers, et al.
Leukemia Research
|
March 8, 2011
Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidine
Jason A Dubovsky, John J Powers, Yang Gao, et al.
Frontiers in Immunology
|
December 17, 2020
HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
Kamira Maharaj, John J Powers, Melanie Mediavilla-Varela, et al.
Leukemia Research
|
September 25, 2010
Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
Jason A Dubovsky, Daniel Wang, John J Powers, et al.
Leukemia & Lymphoma
|
January 29, 2011
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
John J Powers, Jason A Dubovsky, P K Epling-Burnette, et al.
Frontiers in Oncology
|
December 19, 2022
Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma
Ahmad A Tarhini, Wissam B Hanayneh, John J Powers, et al.
Journal of Pediatric Hematology/Oncology
|
June 25, 2020
Plasma of Acute Lymphoblastic Leukemia Patients React to the Culture of a Mycovirus Containing Aspergillus flavus
Cameron K Tebbi, Aruna Badiga, Eva Sahakian, et al.
Biorxiv : the Preprint Server for Biology
|
April 24, 2026
Adaptive Responses Directed by CREB Control Epithelial-Mesenchymal Plasticity in Cancer
Kshitij Parag-Sharma, Harish Bharambe, John J Powers, et al.
Page
of 3